ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•16 Nov 2017 22:57

KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick

KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...

Logo
799 Views
Share
•09 Nov 2017 16:52

Korea, Kospi 200: Targeting 400+

The MSCI Asia Free ex-Japan (MXASJ – 703) regional benchmark, is expected to exceed 1,080 before the bull market that started in 2016 ends, that’s...

Logo
284 Views
Share
•05 Oct 2017 22:59

Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?

Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...

Logo
1.3k Views
Share
•25 Sep 2017 09:29

The Week That Was in NorthAsia@Smartkarma: Sep24

It has been another week in North Asia. North Korean missile/nuclear tests and threats? Check. Trump rhetoric on North Korea and football players?...

Logo
397 Views
Share
•15 Jun 2017 08:46

Sector Capsule: Colour Cosmetics in South Korea

Headlines In 2016, colour cosmetics records value sales growth of 6% to reach KRW2.3 trillion Domestic manufacturers continue to have a large...

x